The NASH group had lower levels of CCO activation in the prefrontal cortex, hippocampus, thalamus, amygdala, and mammillary bodies, which form part of a network underlying spatial working memory. This evidence concerns the gene RYR1 and metabolic dysfunction-associated steatohepatitis.